STAT+: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker?
By
Mario Aguilar
Source
STATSTAT+: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker?statnews.comYou might also wanna read
Personal Reflection on Using Proprietary Medical Devices for Diabetes Management
The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni
sfconservancy.org·6mo ago
FDA Launches Elsa 4.0 AI Tool and Completes Data Platform Consolidation
The FDA announced major modernization steps, including the launch of Elsa 4.0, a significant upgrade to the agency's internal AI tool availa
buff.ly·23d ago
LLMs in Gastroenterology: Balancing Clinical Benefits Against Privacy and Accuracy Risks
This article examines the use of large language models (LLMs) in gastroenterology and hepatology practices. It highlights benefits such as d
mdsc.pe·11d ago
Transforming Medical Data into Reasoning Traces for Improved LLM Clinical Performance
The article discusses how the value of data has shifted in the age of LLMs, arguing that simply having proprietary data is no longer suffici
galsapir.github.io·5mo ago
CGM Toolbox: Expert Resource for Continuous Glucose Monitoring in Diabetes Practice
This article appears to be a resource page for healthcare professionals about continuous glucose monitoring (CGM) in diabetes care. It featu
mdsc.pe·10d ago
How LLMs Are Transforming Preclinical Drug Discovery Data Access
The article discusses how Large Language Models (LLMs) are being applied to preclinical drug discovery to help researchers efficiently acces
Comments
Sign in to join the conversation.
No comments yet. Be the first.